326 related articles for article (PubMed ID: 22208896)
21. Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy.
Upton DH; Ung C; George SM; Tsoli M; Kavallaris M; Ziegler DS
Theranostics; 2022; 12(10):4734-4752. PubMed ID: 35832071
[TBL] [Abstract][Full Text] [Related]
22. Acoustic feedback enables safe and reliable carboplatin delivery across the blood-brain barrier with a clinical focused ultrasound system and improves survival in a rat glioma model.
McDannold N; Zhang Y; Supko JG; Power C; Sun T; Peng C; Vykhodtseva N; Golby AJ; Reardon DA
Theranostics; 2019; 9(21):6284-6299. PubMed ID: 31534551
[TBL] [Abstract][Full Text] [Related]
23. Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system.
Aryal M; Arvanitis CD; Alexander PM; McDannold N
Adv Drug Deliv Rev; 2014 Jun; 72():94-109. PubMed ID: 24462453
[TBL] [Abstract][Full Text] [Related]
24. Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood-brain barrier disruption.
McDannold N; Vykhodtseva N; Hynynen K
Ultrasound Med Biol; 2008 Jun; 34(6):930-7. PubMed ID: 18294757
[TBL] [Abstract][Full Text] [Related]
25. Drug delivery across the blood-brain barrier for the treatment of pediatric brain tumors - An update.
Power EA; Rechberger JS; Gupta S; Schwartz JD; Daniels DJ; Khatua S
Adv Drug Deliv Rev; 2022 Jun; 185():114303. PubMed ID: 35460714
[TBL] [Abstract][Full Text] [Related]
26. Antiangiogenic-targeting drug-loaded microbubbles combined with focused ultrasound for glioma treatment.
Fan CH; Ting CY; Liu HL; Huang CY; Hsieh HY; Yen TC; Wei KC; Yeh CK
Biomaterials; 2013 Mar; 34(8):2142-55. PubMed ID: 23246066
[TBL] [Abstract][Full Text] [Related]
27. Magnetic-resonance imaging for kinetic analysis of permeability changes during focused ultrasound-induced blood-brain barrier opening and brain drug delivery.
Chai WY; Chu PC; Tsai MY; Lin YC; Wang JJ; Wei KC; Wai YY; Liu HL
J Control Release; 2014 Oct; 192():1-9. PubMed ID: 24969355
[TBL] [Abstract][Full Text] [Related]
28. MR-guided focused ultrasound-induced blood-brain barrier opening for brain metastasis: a review.
Grasso G; Torregrossa F; Noto M; Bruno E; Feraco P; Buscemi F; Bartolotta TV; Gagliardo C
Neurosurg Focus; 2023 Aug; 55(2):E11. PubMed ID: 37527681
[TBL] [Abstract][Full Text] [Related]
29. Overview of Current Drug Delivery Methods Across the Blood-Brain Barrier for the Treatment of Primary Brain Tumors.
Haumann R; Videira JC; Kaspers GJL; van Vuurden DG; Hulleman E
CNS Drugs; 2020 Nov; 34(11):1121-1131. PubMed ID: 32965590
[TBL] [Abstract][Full Text] [Related]
30. Targeted Drug Delivery in Brain Tumors-nanochemistry Applications and Advances.
Ganjeifar B; Morshed SF
Curr Top Med Chem; 2021 Oct; 21(14):1202-1223. PubMed ID: 33185163
[TBL] [Abstract][Full Text] [Related]
31. Blood-brain barrier opening with focused ultrasound in Parkinson's disease dementia.
Gasca-Salas C; Fernández-Rodríguez B; Pineda-Pardo JA; Rodríguez-Rojas R; Obeso I; Hernández-Fernández F; Del Álamo M; Mata D; Guida P; Ordás-Bandera C; Montero-Roblas JI; Martínez-Fernández R; Foffani G; Rachmilevitch I; Obeso JA
Nat Commun; 2021 Feb; 12(1):779. PubMed ID: 33536430
[TBL] [Abstract][Full Text] [Related]
32. Closed-loop control of targeted ultrasound drug delivery across the blood-brain/tumor barriers in a rat glioma model.
Sun T; Zhang Y; Power C; Alexander PM; Sutton JT; Aryal M; Vykhodtseva N; Miller EL; McDannold NJ
Proc Natl Acad Sci U S A; 2017 Nov; 114(48):E10281-E10290. PubMed ID: 29133392
[TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance imaging enhanced by superparamagnetic iron oxide particles: usefulness for distinguishing between focused ultrasound-induced blood-brain barrier disruption and brain hemorrhage.
Liu HL; Hsu PH; Chu PC; Wai YY; Chen JC; Shen CR; Yen TC; Wang JJ
J Magn Reson Imaging; 2009 Jan; 29(1):31-8. PubMed ID: 19097103
[TBL] [Abstract][Full Text] [Related]
34. High intensity focused ultrasound technology, its scope and applications in therapy and drug delivery.
Phenix CP; Togtema M; Pichardo S; Zehbe I; Curiel L
J Pharm Pharm Sci; 2014; 17(1):136-53. PubMed ID: 24735765
[TBL] [Abstract][Full Text] [Related]
35. New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting.
Doolittle ND; Abrey LE; Bleyer WA; Brem S; Davis TP; Dore-Duffy P; Drewes LR; Hall WA; Hoffman JM; Korfel A; Martuza R; Muldoon LL; Peereboom D; Peterson DR; Rabkin SD; Smith Q; Stevens GH; Neuwelt EA
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):421-8. PubMed ID: 15701824
[TBL] [Abstract][Full Text] [Related]
36. Focused ultrasound delivery of Raman nanoparticles across the blood-brain barrier: potential for targeting experimental brain tumors.
Diaz RJ; McVeigh PZ; O'Reilly MA; Burrell K; Bebenek M; Smith C; Etame AB; Zadeh G; Hynynen K; Wilson BC; Rutka JT
Nanomedicine; 2014 Jul; 10(5):1075-87. PubMed ID: 24374363
[TBL] [Abstract][Full Text] [Related]
37. Combined local blood-brain barrier opening and systemic methotrexate for the treatment of brain tumors.
Cooper I; Last D; Guez D; Sharabi S; Elhaik Goldman S; Lubitz I; Daniels D; Salomon S; Tamar G; Tamir T; Mardor R; Fridkin M; Shechter Y; Mardor Y
J Cereb Blood Flow Metab; 2015 Jun; 35(6):967-76. PubMed ID: 25669901
[TBL] [Abstract][Full Text] [Related]
38. The influence of the blood-brain barrier in the treatment of brain tumours.
Rathi S; Griffith JI; Zhang W; Zhang W; Oh JH; Talele S; Sarkaria JN; Elmquist WF
J Intern Med; 2022 Jul; 292(1):3-30. PubMed ID: 35040235
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
[TBL] [Abstract][Full Text] [Related]
40. Nanobiotechnology-based delivery strategies: New frontiers in brain tumor targeted therapies.
Mangraviti A; Gullotti D; Tyler B; Brem H
J Control Release; 2016 Oct; 240():443-453. PubMed ID: 27016141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
